NCT03927911 - Phase 4 Study in Adult Subjects Undergoing Posterior Lumbar Spine Surgeries | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2019

Primary Completion Date

August 4, 2020

Study Completion Date

August 4, 2020

Conditions

Postoperative Pain Management

Interventions

DRUG

EXPAREL and Bupivacaine

Drug: EXPAREL and Bupivacaine HCl 0.5%

DRUG

Standard of Care

Trial Locations (12)

M3-Emerging Medical Research, LLC, Durham

Carolina NeuroSurgery & Spine Associates, P.A., Charlotte

University of Miami, Miami

Marcus Neuroscience Institute, Boca Raton

The Orthopaedic Institute of Western Kentucky, Paducah

The Ohio State University, Columbus

Bronson Methodist Hospital, Kalamazoo

Mayo Clinic, Rochester

NorthShore University HealthSystem, Evanston

First Surgical Hospital, Bellaire

Summit Spine Institute, Portland

Yale School of Medicine, New Haven